Bilateral eardrum perforation after long-term treatment with erlotinib.
Lee
Slow Ming
SM
Department of Oncology, University College Hospital London, London, United Kingdom.
Buchler
Tomas
T
Joseph
Theo
T
Lai
Cecilia
C
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000188:drug therapy; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects*; D018058:Tympanic Membrane Perforation / Q000139:chemically induced* / Q000188:drug therapy
D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride